Laboratory of Biological Modeling, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 12A, Room 4007, 12 South Drive MSC 5621, Bethesda, MD 20892-5621, USA.
Int Immunol. 2010 Jul;22(7):571-82. doi: 10.1093/intimm/dxq041. Epub 2010 May 24.
Recent experimental evidence suggests that antigenic stability facilitates antigen shuttling from target tissue to dendritic cells (DCs), enabling cross-priming of naive T cells. On the other hand, antigenic stability affects the efficiency of peptide-MHC (p-MHC) complex formation, altering a target cell's susceptibility to killing by the resulting CTLs. Using a mathematical model, we show how antigenic stability and p-MHC production efficiency interplay in autoantigenicity and pathogenic potential of target cell proteins in autoimmune disease. We consider protein allocated to both rapidly degraded versus stable functional pools [fractions f, 1 - f], contributing, with relative efficiency eta, to p-MHC presentation on a target cell, as well as to cross-presentation on a DC; we analyze the combined effect of these parameters. Our results suggest that autoantigenicity and pathogenicity (ability to elicit T cell activation versus target cell lysis) are not equivalent and that pathogenicity peaks at low to moderate levels of autoantigenicity.
最近的实验证据表明,抗原稳定性有助于抗原从靶组织转移到树突状细胞 (DC),从而实现对幼稚 T 细胞的交叉呈递。另一方面,抗原稳定性会影响肽-MHC (p-MHC) 复合物形成的效率,从而改变靶细胞对由此产生的 CTL 杀伤的敏感性。我们使用数学模型展示了抗原稳定性和 p-MHC 产生效率如何在自身抗原性和自身免疫性疾病中靶细胞蛋白的致病潜力中相互作用。我们考虑分配到快速降解和稳定功能池的蛋白质 [分数 f,1 - f],以相对效率 eta 贡献于靶细胞上的 p-MHC 呈递,以及 DC 上的交叉呈递;我们分析了这些参数的综合影响。我们的结果表明,自身抗原性和致病性(引发 T 细胞激活的能力与靶细胞裂解的能力)并不等同,并且致病性在低到中等水平的自身抗原性时达到峰值。